Triptolide (PG490)

Catalog No.S3604 Synonyms: NSC 163062

For research use only.

Triptolide (PG490, NSC 163062) is a diterpene triepoxide, immunosuppresive agent extracted from the Chinese herb Tripterygium wilfordii. It functions as a NF-κB inhibitor with dual actions by disruption of p65/CBP interaction and by reduction of p65 protein. Triptolide (PG490) abrogates the transactivation function of heat shock transcription factor 1 (HSF1). Triptolide inhibits MDM2 and induces apoptosis through a p53-independent pathway.

Triptolide (PG490) Chemical Structure

CAS No. 38748-32-2

Selleck's Triptolide (PG490) has been cited by 27 publications

Purity & Quality Control

Choose Selective ADC Cytotoxin Inhibitors

Biological Activity

Description Triptolide (PG490, NSC 163062) is a diterpene triepoxide, immunosuppresive agent extracted from the Chinese herb Tripterygium wilfordii. It functions as a NF-κB inhibitor with dual actions by disruption of p65/CBP interaction and by reduction of p65 protein. Triptolide (PG490) abrogates the transactivation function of heat shock transcription factor 1 (HSF1). Triptolide inhibits MDM2 and induces apoptosis through a p53-independent pathway.
Targets
NF-κB [1]
()
HSF1 [1]
()
Mdm2 [1]
()
In vitro

Triptolide is a diterpene triepoxide with potent immunosuppressive and antiinflammatory properties. Triptolide is shown to inhibit the expression of IL-2 in activated T cells at the level of purine-box/nuclear factor and NF-κB mediated transcription activation. [1] Triptolide inhibits the proliferation and colony formation of tumor cells at extremely low concentrations (2–10 ng/mL). Triptolide has an inhibitory activity on breast, stomach and leukemia cell line HL-60 cells. Triptolide induces apoptosis in tumor cells by blocking NF-κB activation and sensitizing tumor cells for TNF-&alpha induced programmed cell death. [2]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
HT-29 MnfGR5l1d3SxeHnjbZR6KGGpYXnud5Q> NGe2U3hEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBJXC1{OTDj[YxteyxiSVO1NF0xNjByMkJOwG0> NGTZXG09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUS3NFg3PCd-MkG0O|A5PjR:L3G+
HCT116 MUDDfZRwfG:6aXPpeJkh[WejaX7zeC=> NWrEO3FPS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hUEOWMUG2JINmdGy|IHHzd4V{e2WmIHHzJIRm[3KnYYPlJIlvKGOnbHygeoli[mmuaYT5MEBKSzVyPUCuNFA1P87:TR?= NH;Pc289[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MUGyNVU1Pid-M{GxNlE2PDZ:L3G+
SKOV3 NGD5bFVCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0 MWK3NkBpenN? M{XpNWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iU1vPWlMh[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IGPSRkBie3OjeTygTWM2OD1yLkCwOu69VQ>? M{iwSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyOEOzOVQ{Lz5{MEizN|U1OzxxYU6=
SKOV3 M{XWbWN6fG:2b4jpZ4l1gSCjZ3HpcpN1 NELYSHE4OiCqcoO= MVjDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDTT29XOyClZXzsd{Bi\nSncjC3NkBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiSVO1NF0xNjByNt88US=> MkXNQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR|N{i3NFkoRjJ2M{e4O|A6RC:jPh?=
SKOV3 NIfPbolEgXSxdH;4bYMh[WO2aY\peJkh[WejaX7zeC=> M1W0cFczKGi{cx?= MYnDfZRwfG:6aXOgZYN1cX[rdImgZYdicW6|dDDoeY1idiCVS1;WN{Bk\WyuczDhd5Nme3OnZDDhd{Bz\WS3Y4Tpc44hcW5iY3XscEB3cWGkaXzpeJkh[W[2ZYKgO|IhcHK|IHL5JHNTSiCjc4PhfUwhUUN3ME2wMlAxPzMQvF2= NUXRR2xjRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkiwNVEzOjNpPkK4NFEyOjJ|PD;hQi=>
KBM5 NXXKZpNOS3m2b4TvfIlkcXS7IHHnZYlve3R? NXzOcXRjPzJiaILz MWPDfZRwfG:6aXPpeJkh[WejaX7zeEBqdWG2aX7pZk1z\XOrc4ThcpQhcHWvYX6gT2JOPSClZXzsd{Bp[XKkb4LpcochSmO{LVHicEBVOzF3STDteZRidnRiYX\0[ZIhPzJiaILzJIJ6KE2WUzDhd5NigSxiSVO1NF0xNjByOEROwG0> MYi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zODF2OU[2OUc,OjBzNEm2OlU9N2F-
SKOV3 NFv5[WlEgXSxdH;4bYNqfHliYXfhbY5{fA>? M4Pu[GN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJHNMV1Z|IHPlcIx{KGK7IGPSRkBie3OjeTygTWM2OD1yLkCwPe69VQ>? NHn4V|k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOU[zO|g4PCd-MUm2N|c5PzR:L3G+
MDA-MB-468 MnOwR5l1d3SxeHnjbZR6KGGpYXnud5Q> M2DkbmN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJG1FSS2PQj20Olgh[2WubIOgZpkhW1KEIHHzd4F6NCCLQ{WwQVAvODIQvF2= M{T5eFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7NkO3PFc1Lz5zOU[zO|g4PDxxYU6=
HCT116 MYPDfZRwfG:6aXPpeJkh[WejaX7zeC=> MnzCO|IhcHK| M{HtWmN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGhEXDFzNjDj[YxteyCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwQVAvODIQvF2= M{PlU|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7NkO3PFc1Lz5zOU[zO|g4PDxxYU6=
SKOV3 M{\3NmN6fG:2b4jpZ4l1gSCjZ3HpcpN1 MV63NkBpenN? NFSwSpdEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBUU0:YMzDj[YxteyCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwQVAvODIQvF2= MkjnQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl4M{e4O|QoRjF7NkO3PFc1RC:jPh?=
KBM5 MlP1R5l1d3SxeHnjbZR6KGGpYXnud5Q> MWS3NkBpenN? M2j2bmN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGtDVTViY3XscJMhcGG{Yn;ybY5oKHerbHSgeJlx\SCEY4KtRYJtKGGodHXyJFczKGi{czDifUBOXFNiYYPzZZktKEmFNUC9NE4xOTB|zszN MU[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zODF2OU[2OUc,OjBzNEm2OlU9N2F-
Rh30 MVzDfZRwfG:6aXPpeJkh[WejaX7zeC=> MoTlO|IhcHK| M{\DeGN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJHJpOzBiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JG1VXCCjc4PhfUwhUUN3ME2wMlAyPM7:TR?= M{TPPFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7NkO3PFc1Lz5zOU[zO|g4PDxxYU6=
A549 NGfUVmRCdnSjZ3;ubZN1KGGldHn2bZR6KGG2 NF;Tc4pCdnSjZ3;ubZN1KGGldHn2bZR6KGG2IHj1cYFvKFCDUkKg[ZhxemW|c3XkJIlvKGi3bXHuJGE2PDliY3XscJMh[XO|ZYPz[YQh[XNiaX7obYJqfGmxbjDv[kAz\i2OSVfSUG8uVkh{LXnu[JVk\WRiTl\rZZBx[UJiYXP0bZZifGmxbjDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[XluIFnDOVA:OC5yMUVOwG0> NIS1c5k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{i5OVQ6Oid-MkO4PVU1QTJ:L3G+
SGC7901 Ml76R5l1d3SxeHnjbZR6KGGpYXnud5Q> NW\UZ3d6PzJiaILz MYfDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDTS2M4QTBzIHPlcIx{KGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEmFNUC9NE4xOTYQvF2= M4nHPVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7NkO3PFc1Lz5zOU[zO|g4PDxxYU6=
MOLT4 M3TvTGN6fG:2b4jpZ4l1gSCjZ3HpcpN1 NFLDWWc4OiCqcoO= MUXDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDNU2xVPCClZXzsd{Bi\nSncjC3NkBpenNiYomgUXRVKGG|c3H5MEBKSzVyPUCuNFE4|ryP NVj3[mNORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUm2N|c5PzRpPkG5OlM4QDd2PD;hQi=>
A549 NVLvN25DS3m2b4TvfIlkKGGldHn2bZR6KGGpYXnud5Q> Mmm4O|IhcHK| NXuxdWllS3m2b4TvfIlkKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gRVU1QSClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gZ4VtdCC4aXHibYxqfHliYX\0[ZIhPzJiaILzJIJ6KFOUQjDhd5NigSxiSVO1NF0xNjBzN{ZOwG0> NHOzW2M9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OECxNVIzOyd-MkiwNVEzOjN:L3G+
SMMC7721 M4\6eGN6fG:2b4jpZ4l1gSCjZ3HpcpN1 MmrhO|IhcHK| MVvDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDTUW1EPzd{MTDj[YxteyCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwQVAvODF6zszN MmG3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl4M{e4O|QoRjF7NkO3PFc1RC:jPh?=
PC3 NXf0WmJyS3m2b4TvfIlkKGGldHn2bZR6KGGpYXnud5Q> M3jVdlczKGi{cx?= MoLTR5l1d3SxeHnjJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iUFOzJINmdGy|IHHzd4V{e2WmIHHzJJJm\HWldHnvckBqdiClZXzsJJZq[WKrbHn0fUBi\nSncjC3NkBpenNiYomgV3JDKGG|c3H5MEBKSzVyPUCuNFE5O87:TR?= MYm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDBzMUKyN{c,OjhyMUGyNlM9N2F-
MCF7 MkDkR5l1d3SxeHnjbZR6KGGpYXnud5Q> M1vQXVczKGi{cx?= MU\DfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDNR2Y4KGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDNWHQh[XO|YYmsJGlEPTB;MD6wNVnPxE1? MoTIQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl4M{e4O|QoRjF7NkO3PFc1RC:jPh?=
A549 M2Dq[GN6fG:2b4jpZ4l1gSCjZ3HpcpN1 MWrDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDBOVQ6KGOnbHzzMEBKSzVyPUCuNFE6|ryP MnPtQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF2N{C4OlQoRjJzNEewPFY1RC:jPh?=
PC3 NXP5[lQ4S3m2b4TvfIlkcXS7IHHnZYlve3R? MWDDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDQR|Mh[2WubIOgZpkhW1KEIHHzd4F6NCCLQ{WwQVAvODMQvF2= MXW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTZ|N{i3OEc,OTl4M{e4O|Q9N2F-
Bel7402 MUPDfZRwfG:6aXPpeJkh[WejaX7zeC=> NF62PZU4OiCqcoO= NEnxXnNEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBD\Wx5NECyJINmdGy|IHHmeIVzKDd{IHjyd{BjgSCPVGSgZZN{[XluIFnDOVA:OC5yMt88US=> M3y1WlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7NkO3PFc1Lz5zOU[zO|g4PDxxYU6=
PC3 MYrBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2 MX23NkBpenN? MkLmRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCSQ{OgZ4VtdHNiYX\0[ZIhPzJiaILzJIJ6KFOUQjDhd5NigSxiSVO1NF0xNjB{zszN M2XvfVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyOEOzOVQ{Lz5{MEizN|U1OzxxYU6=
PC3 MnzVR5l1d3SxeHnjbZR6KGGpYXnud5Q> M2K0TVczKGi{cx?= M4HZOWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJHBEOyClZXzsd{Bi\nSncjC3NkBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiSVO1NF0xNjB{zszN MoPuQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR|N{i3NFkoRjJ2M{e4O|A6RC:jPh?=
PC3 M4HWWGN6fG:2b4jpZ4l1gSCjZ3HpcpN1 MULDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDQR|Mh[2WubIOgZZN{\XO|ZXSgZZMhcW6qaXLpeIlwdiCxZjDj[YxtKHC{b3zp[oVz[XSrb36gZpkhe3WuZn;ybI9l[W2rbnWgRkBie3OjeTygTWM2OD1yLkCy{txO M1zUNFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NE[3NVU5Lz5{NUS2O|E2QDxxYU6=
786-O MkfOR5l1d3SxeHnjbZR6KGGpYXnud5Q> NFXPR2w4OiCqcoO= Mnz1R5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gO|g3NU9iY3XscJMh[W[2ZYKgO|IhcHK|IHL5JG1VXCCjc4PhfUwhUUN3ME2wMlAzOs7:TR?= MXi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTZ|N{i3OEc,OTl4M{e4O|Q9N2F-
A549 NG\UVGVCdnSjZ3;ubZN1KGGldHn2bZR6KGG2 MV;BcpRi\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHBCWjJiZYjwdoV{e2WmIHnuJIh2dWGwIFG1OFkh[2WubIOgZ49mgHC{ZYPzbY5oKFSDQ2KxJIF{e2W|c3XkJIF{KGmwaHnibZRqd25ib3[gd5Vje3SjbnPlJHAucW6mdXPl[EBKVC16IIDyc4R2[3Srb36gZpkhTUyLU1GsJGlEPTB;MD6wNlPPxE1? M4P5eFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|OEm1OFkzLz5{M{i5OVQ6OjxxYU6=
MDA-MB-231 MlLqR5l1d3SxeHnjbZR6KGGpYXnud5Q> M2LXWFczKGi{cx?= M2T5UmN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJG1FSS2PQj2yN|Eh[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IF3UWEBie3OjeTygTWM2OD1yLkCyOO69VQ>? MXe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTZ|N{i3OEc,OTl4M{e4O|Q9N2F-
DU145 MYnDfZRwfG:6aXPpeJkh[WejaX7zeC=> NGHubWY4OiCqcoO= M1;KNGN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGRWOTR3IHPlcIx{KGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEmFNUC9NE4xOjUQvF2= M3\Z[FxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7NkO3PFc1Lz5zOU[zO|g4PDxxYU6=
HO8910 MX3DfZRwfG:6aXPpeJkh[WejaX7zeC=> NFq1bXc4OiCqcoO= Mon5R5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gTG85QTFyIHPlcIx{KGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEmFNUC9NE4xOjkQvF2= M1GySVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7NkO3PFc1Lz5zOU[zO|g4PDxxYU6=
HCT15 NHTK[FREgXSxdH;4bYNqfHliYXfhbY5{fA>? NE\ld2s4OiCqcoO= NIjYT4lEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBJS1RzNTDj[YxteyCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwQVAvODJ7zszN NGP3WHE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOU[zO|g4PCd-MUm2N|c5PzR:L3G+
A549 M{nzS2dzd3e2aDDpcohq[mm2aX;uJI9nKGi3bXHu MYnHdo94fGhiaX7obYJqfGmxbjDv[kBpfW2jbjDBOVQ6KGOnbHzzMEBKSzVyPUCuNFPPxE1? M3PQSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6OEG0N|c1Lz5{OEixOFM4PDxxYU6=
32D Ml3tR5l1d3SxeHnjbZR6KGGpYXnud5Q> MWW3NkBpenN? NFS5fI9EgXSxdH;4bYNqfHliYXfhbY5{fCCvb4Xz[UA{OkRiY3XscJMhcGG{Yn;ybY5oKHerbHSgeJlx\SCEY4KtRYJtKGGodHXyJFczKGi{czDifUBOXFNiYYPzZZktKEmFNUC9NE4xOzMQvF2= MU[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zODF2OU[2OUc,OjBzNEm2OlU9N2F-
U251 MlXpR5l1d3SxeHnjbZR6KGGpYXnud5Q> NUO3[pZ6S3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hXTJ3MTDj[YxteyCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKGOnbHygdJJwdGmoZYLheIlwdiCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCLQ{WwQVAvODN|zszN MmjHQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV2NkexOVgoRjJ3NE[3NVU5RC:jPh?=
32D NVWwflF[S3m2b4TvfIlkcXS7IHHnZYlve3R? NYrldJFNPzJiaILz NV7oblRuS3m2b4TvfIlkcXS7IHHnZYlve3RiaX3heIlvcWJvcnXzbZN1[W62IH3veZNmKDN{RDDj[YxteyCqYYLic5JqdmdiQnPyMWFjdCCWM{G1TUBufXSjboSgZYZ1\XJiN{KgbJJ{KGK7IF3UV{Bie3OjeTygTWM2OD1yLkCzOO69VQ>? MkjuQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjBzNEm2OlUoRjJyMUS5OlY2RC:jPh?=
PC3 MX\DfZRwfG:6aXPpeJkh[WejaX7zeC=> MYW3NkBpenN? NI\mU5JEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBRSzNiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JG1VXCCjc4PhfUwhUUN3ME2wMlA1O87:TR?= MWq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTZ|N{i3OEc,OTl4M{e4O|Q9N2F-
KB MYnDfZRwfG:6aXPpeJkh[WejaX7zeC=> MoDWO|IhcHK| MmPyR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gT2Ih[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IF3UWEBie3OjeTygTWM2OD1yLkC0N:69VQ>? MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTZ|N{i3OEc,OTl4M{e4O|Q9N2F-
HepG2 MXLDfZRwfG:6aXPpeJkh[WejaX7zeC=> MoDtOFghcHK| M4roV2N6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGhmeEd{IHPlcIx{KGGodHXyJFQ5KGi{czDifUBZXFRiYYPzZZktKEmFNUC9NE4xPDN|zszN MX28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODZzM{OzOUc,OzB4MUOzN|U9N2F-
HeLa NWjGem1CS3m2b4TvfIlkcXS7IHHnZYlve3R? NUfpUmo2PzJiaILz MoDFR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gTIVN[SClZXzsd{Bi\nSncjC3NkBpenNiYomgUXRVKGG|c3H5MEBKSzVyPUCuNFQ4|ryP NW[3OYRLRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUm2N|c5PzRpPkG5OlM4QDd2PD;hQi=>
U251 NGrtWlZEgXSxdH;4bYNqfHliYXfhbY5{fA>? M4n2T|czKGi{cx?= NXHlVXN[S3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hXTJ3MTDj[YxteyCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwQVAvODR7zszN MoH2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl4M{e4O|QoRjF7NkO3PFc1RC:jPh?=
K562 M13HdmN6fG:2b4jpZ4l1gSCjZ3HpcpN1 NVLCdYJDPzJiaILz MmjzR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gT|U3OiClZXzsd{Bi\nSncjC3NkBpenNiYomgUXRVKGG|c3H5MEBKSzVyPUCuNFXPxE1? M1fVVFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7NkO3PFc1Lz5zOU[zO|g4PDxxYU6=
NIH/3T3 NUS5W3oxS3m2b4TvfIlkcXS7IHHnZYlve3R? M4rVdWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KG2xdYPlJG5KUC9|VEOgZ4VtdHNiYYPz[ZN{\WRiYYOg[IVkemWjc3WgbY4h[2WubDD2bYFjcWyrdImsJGlEPTB;MD6wOe69VQ>? NYjmZYtyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxM{GxNlE2PDZpPkOxNVIyPTR4PD;hQi=>
SW1116 NYnxfHcyS3m2b4TvfIlkcXS7IHHnZYlve3R? MWW3NkBpenN? NF3X[XpEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBUXzFzMU[gZ4VtdHNiYX\0[ZIhPzJiaILzJIJ6KE2WVDDhd5NigSxiSVO1NF0xNjB3Mt88US=> NWLDVXV4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUm2N|c5PzRpPkG5OlM4QDd2PD;hQi=>
A549 M1rEXmN6fG:2b4jpZ4l1gSCjZ3HpcpN1 M3e1eFczKGi{cx?= MmnhR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gRVU1QSClZXzsd{Bi\nSncjC3NkBpenNiYomgUXRVKGG|c3H5MEBKSzVyPUCuNFU6|ryP MmfBQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl4M{e4O|QoRjF7NkO3PFc1RC:jPh?=
HeLa MlzMR5l1d3SxeHnjbZR6KGGpYXnud5Q> NV[yS4J5S3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hUGWOYTDj[YxteyCjc4Pld5Nm\CCjczDk[YNz\WG|ZTDpckBk\WyuII\pZYJqdGm2eTygTWM2OD1yLkC4O:69VQ>? NF;2cXQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MUGyNVU1Pid-M{GxNlE2PDZ:L3G+
Jurkat NEDpRZFEgXSxdH;4bYNqfHliYXfhbY5{fA>? NVLQSGN2S3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hUnW{a3H0JINmdGy|IHHzd4V{e2WmIHHzJIRm[3KnYYPlJIlvKGOnbHygeoli[mmuaYT5MEBKSzVyPUCuNVTPxE1? MYK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{OTF{MUW0Okc,OzFzMkG1OFY9N2F-
MKN28 MoX5R5l1d3SxeHnjbZR6KGGpYXnud5Q> MkHwO|IhcHK| MXfDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDNT24zQCClZXzsd{Bi\nSncjC3NkBpenNiYomgUXRVKGG|c3H5MEBKSzVyPUCuNu69VQ>? M4HEZVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7NkO3PFc1Lz5zOU[zO|g4PDxxYU6=
MDCK NH\jTYZEgXSxdH;4bYNqfHliYXfhbY5{fA>? NHTV[o1EgXSxdH;4bYNqfHliYXfhbY5{fCCPRFPLJINmdGy|IHHzd4V{e2WmIHHzJIRm[3KnYYPlJIlvKGOnbHygeoli[mmuaYT5MEBKSzVyPUGuNu69VQ>? NEXaSJU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MUGyNVU1Pid-M{GxNlE2PDZ:L3G+
Pkd1-/- MYnJcoR2[3Srb36gc4Y> MUfJcoR2[3Srb36gc4Yh[2WubDDndo94fGhiYYLy[ZN1KGmwIH3veZNmKFCtZEGtM{0h[2WubIOgbY4heHKnc3XuZ4Uhd2ZiY3HsZ4l2dQ>? MX68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPzN4MEWzOEc,OTd|NkC1N|Q9N2F-
Pkd1-/- NYTIcXl1UW6lcnXhd4UhcW5? NF35fI0yODBibl2= M2HO[lk3KGi{cx?= NXPKboZkUW6lcnXhd4UhcW5icEKxR2lRN1eDRjDlfJBz\XO|aX;uJIlvKG2xdYPlJHBs\DFvLz2gZ4VtdHNiYYSgNVAxKG6PIHHmeIVzKDl4IHjyd{BjgSCZZYP0[ZJvKGKub4SgZY5idHm|aYO= MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPzN4MEWzOEc,OTd|NkC1N|Q9N2F-
Pkd1+/- NXzENYEyUW6lcnXhd4UhcW5? Mn7LNVAxKG6P NXLqeVh{UW6lcnXhd4UhcW5iUFOyJIRmeGWwZHXueEBk[WylaYXtJJJmdGWjc3WgbY4hdW:3c3WgVItlOStxLTDj[YxteyCjdDCxNFAhdk1? Mm\aQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTd|NkC1N|QoRjF5M{[wOVM1RC:jPh?=
Pkd1-/- M4DtVGlv[3KnYYPlJIlv NGfuW2EyODBibl2= MnK4TY5kemWjc3WgbY4hWEN{IHTldIVv\GWwdDDjZYxkcXWvIILlcIVie2ViaX6gcY92e2ViUHvkNU0wNSClZXzsd{BifCBzMECgcm0> NIHn[|Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{O2NFU{PCd-MUezOlA2OzR:L3G+
Pkd1-/- NVLCVG5zUW6lcnXhd4UhcW5? MY[1NEB2VQ>? MoPiTY5kemWjc3WgbY4h[2GuY3n1cUBz\WynYYPlJIlvKG2xdYPlJHBs\DFvLz2gZ4VtdHNiYYSgOVAhfU1iaX6gdJJme2WwY3Wgc4YhWnmUIHHueIFod26rc4Sg[IFvfHKxbHXu[S=> MYG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPzN4MEWzOEc,OTd|NkC1N|Q9N2F-
Pkd2+/- NYjFT4ZST3Kxd4ToJIlvcGmkaYTpc44hd2ZiUFOyJIV5eHKnc4PpcochdW:3c3W= NXvyfm4xOTByIH7N M4G5UVI1KGi{cx?= Mo[2S5Jwf3SqIHnubIljcXSrb36gc4YhWEN{IHX4dJJme3OrbnegcY92e2ViUHvkNkswNSClZXzsd{BieyClZXzsJIRm[XSqIHH0JFExOCCwTTDh[pRmeiB{NDDodpM> MlfBQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTd|NkC1N|QoRjF5M{[wOVM1RC:jPh?=
KBM5 NFXFSYNEgXSxdH;4bYNqfHliYXfhbY5{fA>? MnTqNE4xODFidH:gNVchfU1? MVq3NkBpenN? MnjnR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gT2JOPSClZXzsd{Bp[XKkb4Lpcochf2muZDD0fZBmKEKlcj3BZowh[XRiMD6wNFEhfG9iMUegeW0h[W[2ZYKgO|IhcHK|IHL5JG1VWyCjc4PhfS=> MljBQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjBzNEm2OlUoRjJyMUS5OlY2RC:jPh?=
KBM5 MUfDfZRwfG:6aXPpeJkh[WejaX7zeC=> MoTNNE4xODFidH:gNVchfU1? M3K0cFczKGi{cx?= NIezc5hEgXSxdH;4bYNqfHliYXfhbY5{fCCrbXH0bY5q[i2{ZYPpd5RidnRiaIXtZY4hU0KPNTDj[YxteyCqYYLic5JqdmdiQnPyMWFjdCCWM{G1TUBufXSjboSgZZQhOC5yMEGgeI8hOTdidV2gZYZ1\XJiN{KgbJJ{KGK7IF3UV{Bie3OjeR?= M4XKT|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyMUS5OlY2Lz5{MEG0PVY3PTxxYU6=
LNCAP MV7BcpRi\2:waYP0JIFkfGm4aYT5JIF1 M2SzZVUhfU1? MUOyOEBpenN? MnfqRY51[WexbnnzeEBi[3Srdnn0fUBifCCDUjDpckBpfW2jbjDMUmNCWCClZXzsd{Bie3Onc4Pl[EBieyC|dYDwdoV{e2mxbjDv[kBFUFRvaX7keYNm\CC{ZXPldJRweiC2cnHud4NzcXC2aX;uZYwh[WO2aY\peJkh[XRiNTD1UUBi\nSncjCyOEBpenNiYomg[JVidCCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYm= NEXCUHk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{m5OFc{OSd-Mke5PVQ4OzF:L3G+
LNCAP Moe2RY51[WexbnnzeEBi[3Srdnn0fUBifA>? MlXHOVAxKG6P NH;EU5gzPCCqcoO= NYrhb2JKSW62YXfvcol{fCCjY4Tpeol1gSCjdDDBVkBqdiCqdX3hckBNVkODUDDj[YxteyCjc4Pld5Nm\CCjczDzeZBxemW|c3nvckBw\iCGSGStbY5lfWOnZDDy[YNmeHSxcjD0doFve2O{aYD0bY9v[WxiYXP0bZZqfHliYYSgOVAxKG6PIHHmeIVzKDJ2IHjyd{BjgSCmdXHsJIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigQ>? MmTPQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjd7OUS3N|EoRjJ5OUm0O|MyRC:jPh?=
HepG2 MmXpRY51cXS3bX;yJIFkfGm4aYT5JIFo[Wmwc4S= NWTQU2NsOC5{IH3nM4to M3vOTFE2KGSjeYO= NYHaNIhRSW62aYT1cY9zKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gTIVxTzJiY3XscJMhgGWwb3fyZYZ1\WRiaX6gRoFt[i:lIH71[IUhdW:3c3WgZZN{\XO|ZXSgZZMhemWmdXP0bY9vKGmwIIT1cY9zKGe{b4f0bEBifCByLkKgcYcwc2duIHnwJIFldWmwaYP0[ZJm\CCxbnPlJIRicWy7IH\vdkAyPSCmYYnz NXnlR2RpRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxM{C2NVM{OzVpPkOwOlE{OzN3PD;hQi=>
Assay
Methods Test Index PMID
Western blot c-Jun ; MDM2 ; p-AKT / AKT / p-Foxo3a / Foxo3a / p53 ; p-PI3K / PI3K / p85 / p110 22666381 27004407
Growth inhibition assay Cell viability 22666381
In vivo Triptolide synergizes with cyclosporin A in promoting graft survival in animal models and in suppression of graft versus host disease in allogeneic bone marrow transplants. In addition, it induces apoptosis in tumor cells and potentiates tumor necrosis factor (TNF-α) induction of apoptosis in part through the suppression of c-IAP2 and c-IAP1 induction. [1] [3] Triptolide treatment for 2–3 weeks inhibits the growth of xenografts formed by four different tumor cell lines (B16 melanoma, MDA-435 breast cancer, TSU bladder cancer, and MGC80-3 gastric carcinoma), indicating that TPL has a broad spectrum of activity against tumors that contain both wild-type and mutant forms of p53. In addition, Triptolide inhibits experimental metastasis of B16F10 cells to the lungs and spleens of mice. [2] Triptolide has in vitro and in vivo activities against mouse models of polycystic kidney disease. [4] LD50: Mice 0.83mg/kg (i.v.). [5]

Protocol (from reference)

Solubility (25°C)

In vitro

DMSO 72 mg/mL warmed
(199.77 mM)
Water Insoluble
Ethanol Insoluble

In vivo

Add solvents to the product individually and in order
(Data is from Selleck tests instead of citations):
2% DMSO+30% PEG 300+2% Tween 80+ddH2O
For best results, use promptly after mixing.

3mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 360.4
Formula

C20H24O6

CAS No. 38748-32-2
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles CC(C)C12C(O1)C3C4(O3)C5(CCC6=C(C5CC7C4(C2O)O7)COC6=O)C

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Triptolide (PG490) | Triptolide (PG490) supplier | purchase Triptolide (PG490) | Triptolide (PG490) cost | Triptolide (PG490) manufacturer | order Triptolide (PG490) | Triptolide (PG490) distributor